Endocrine-disrupting chemicals (EDCs) have significant impacts on biological systems, and
have been shown to interfere with physiological systems, especially by disrupting the …

Bisphenol A (BPA; 4, 4′-isopropylidenediphenol) is a well-known endocrine disruptor. Most
human exposure to BPA occurs through the consumption of BPA-contaminated foods …

A scarcity of research assesses the effects of exposure to a combination of chemicals on
lipid profiles as well as molecular mechanisms related to dyslipidemia. A cross-sectional …

Previous evidences exploring the associations of BPA with lipid changes and dyslipidemia
did not obtain consistent results. To evaluate whether serum BPA concentration was …

Background The connection between urinary bisphenol A (BPA) and hyperlipidemia is still
unclear, and few studies have evaluated whether urinary BPA affects mortality among …

Highlights Bisphenola A (BPA) is an endocrine disruptor widely investigated as a possible
environmental contributor to the pathogenesis of Polycystic Ovary Syndrome (PCOS). Due to …

Background Polycystic ovary syndrome (PCOS) is an endocrine disorder characterized by
anovulation, hyperandrogenism, and polycystic ovarian morphology. Its etiology is uncertain …

Mounting evidence shows that bisphenol A (BPA) is associated with metabolic risk factors.
The aim of this study was to review related epidemiologic studies and conduct a meta …

Dyslipidemia is a prevalent metabolic disorder in older adults and has negative effects on
cardiovascular health. However, the combined effect of paraben, bisphenol A (BPA), and …

Background and aim Bisphenol-A and–S (BPA and BPS), chemicals used in food
packaging, have been associated with risk of insulin resistance and Type 2 diabetes (T2D) …